In the Spotlight - June 2004

July 2nd 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

The company is voluntarily recalling one lot of cefazolin for injection, USP, 1 gram per vial due to customer complaints of the wrong product being included in a carton.

Felicity Thomas

June 25th 2024

Hikma Pharmaceuticals Invests $1 Billion to Expand US Generic Drug Capabilities, Releases Sustainability Report

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

June 30th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

The company is expanding its US manufacturing and R&D capabilities with a $1 billion investment by 2030.

Feliza Mirasol

April 30th 2024

Quattrii Delivers Biologics and mRNA Molecules in Single Inhalation

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

European Pharmacopoeia Goes Digital

Cambridge Healthcare Innovations says its dry powder inhaler engine, Quattrii, can deliver large volumes of biologic and mRNA molecules in a single inhalation.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Sandoz Recalls Cefazolin Due to Mispackaging, Opens Biosimilar Facility in Slovenia

The 12th edition of the European Pharmacopoeia will be an all-digital, redesigned, user-friendly issue.

Related Content

July 2nd 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

The company is voluntarily recalling one lot of cefazolin for injection, USP, 1 gram per vial due to customer complaints of the wrong product being included in a carton.

Felicity Thomas

June 25th 2024

Hikma Pharmaceuticals Invests $1 Billion to Expand US Generic Drug Capabilities, Releases Sustainability Report

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

June 30th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

The company is expanding its US manufacturing and R&D capabilities with a $1 billion investment by 2030.

Feliza Mirasol

April 30th 2024

Quattrii Delivers Biologics and mRNA Molecules in Single Inhalation

European Pharmacopoeia Goes Digital

Cambridge Healthcare Innovations says its dry powder inhaler engine, Quattrii, can deliver large volumes of biologic and mRNA molecules in a single inhalation.